Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (Weighted Average) (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $6.7 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $6.7 million, up 5.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.7 million (up 5.01% YoY), and the FY2025 annual result was $6.6 million, up 3.64% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $6.7 million in Q4 2025 per ZYBT's latest filing, from $6.5 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $6.7 million in Q4 2025 and troughed at $6.3 million in Q4 2023.
• A 3-year average of $6.5 million and a median of $6.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) gained 0.24% in 2024, then advanced 5.01% in 2025.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $6.3 million in 2023, then grew by 0.24% to $6.4 million in 2024, then grew by 5.01% to $6.7 million in 2025.
• Business Quant data shows ZYBT's Shares Outstanding (Weighted Average) at $6.7 million in Q4 2025, $6.5 million in Q2 2025, and $6.4 million in Q4 2024.